Why is Remus Pharma. falling/rising?

As of 12-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 820.55, which reflects a decrease of 20.95 or 2.49%. The stock is close to its 52-week low, being only 0.19% away from the low of Rs 819. Additionally, it has underperformed its sector by 2.78% today. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a notable decline in investor participation, with delivery volume dropping by 4.96% compared to the 5-day average. The stock has also shown poor performance over various time frames, with a year-to-date decline of 34.29% and a one-year decline of 35.13%.
In the broader market context, the Sensex has shown positive returns, gaining 1.51% over the past week and 2.56% over the past month, contrasting sharply with Remus Pharmaceuticals' declines of 2.41% and 2.37% in the same periods. This underperformance against the benchmark suggests that the stock is struggling to attract investor confidence, particularly in a rising market. The lack of available positive factors further emphasizes the challenges faced by Remus Pharmaceuticals, as it continues to lag behind both its sector and the overall market.